VitaDAO, A ‘DeSci DAO,’ Launches Community-Funded Matrix Biosciences Firm

Pfizer-Backed VitaDAO launches Matrix Biosciences for longevity research, in the decentralized science movement (DeSci).
VitaDAO, A ‘DeSci DAO,’ Launches Community-Funded Matrix Biosciences Firm
VitaDAO, A ‘DeSci DAO,’ Launches Community-Funded Matrix Biosciences Firm

Matrix Biosciences is the first biotech company to be established by the decentralized organization VitaDAO, which is devoted to advancing early-stage longevity research.

This comes after the community approved of working with Dr. Vera Gorbunova, who is the co-chair of the Aging Research Center at Rochester University. VitaDAO will give Matrix Bio the initial $300,000 payment and the remaining funds through the IP-NFT fractionalization in early 2024.

The fractionalization of IP-NFT is made possible by the technology used by the VitaDAO-connected platform Molecule. The projects can then be listed by researchers through the marketplace.

These funding will be used for pre-clinical research on substances obtained from long-lived, cancer-resistant naked mole rats with the goal of discovering possible anti-cancer and age-related medicines. The very first Pfizer investment in a DAO was VitaDAO, which received $4.1 million from the company’s venture arm. It has so far provided funding for 19 initiatives, including Turn Biotechnologies and the University of Copenhagen’s study on how medications affect aging.

DeSci is a movement toward decentralized science with the goal of gaining decentralized ownership and obtaining research finance through crowdfunding.

More From The Kangaroo Times

Total
0
Shares
Related Posts
Total
0
Share